Logo Shanghai Yusong Biotechnology : GPS Coordinates 31.2463389 - 121.6270181

Shanghai Yusong Biotechnology - cosmetic lab in China

Shanghai United Cell Biotechnology operates a 20,000sqm biopharmaceutical facility in Shanghai Free Trade Zone, producing vaccines and therapeutic products since 1995.

Presentation of Shanghai Yusong Biotechnology

Shanghai United Cell Biotechnology, established in 1995 in the Shanghai Free Trade Zone, operates a biopharmaceutical facility spanning 20,000 square meters at 1150 Gui Qiao Lu. The company focuses on:

  • Gene-engineered vaccines and therapeutic products
  • Lyophilized powder injections and cartridge water injections
  • Research in endocrinology, orthopedics and ophthalmology
  • GMP-standard manufacturing facilities

With USD 61.15 million in registered capital and expansion to Zhuhai, the company maintains robust R&D programs for growth hormone, osteoporosis and ophthalmic treatments.

Shanghai Yusong Biotechnology newsfeed

  • Shanghai Yusong Biotechnology has not yet been verified. The newsfeed is disabled.

Shanghai Yusong Biotechnology presentation

A leading biotechnology company in Shanghai

Shanghai United Cell Biotechnology, established in 1995, has grown into a prominent biotechnology enterprise within China’s pharmaceutical sector. Operating from the Shanghai Free Trade Zone’s Jinqiao Biotechnology Industrial Park, the company combines advanced research capabilities with state-of-the-art manufacturing facilities.

Advanced facilities and production capabilities

The company’s facility encompasses 44,000 square meters of total space, housing both cosmetic lab operations and pharmaceutical manufacturing units. The production infrastructure includes specialized areas for genetic engineering, vaccine development, and various pharmaceutical formulations.

Manufacturing capacity

  • 15 million freeze-dried injections annually
  • 13 million cartridge vial injections
  • 9 million capsules
  • 5.6 million granule bags

Research and development focus

With over 10% of sales revenue directed towards R&D, Shanghai United Cell Biotechnology maintains active research platforms in multiple therapeutic areas. The company’s work spans across:

  • Endocrinology
  • Orthopedics
  • Ophthalmology
  • Anti-infection treatments

Product portfolio and expertise

Operating under strict GMP compliance, the company produces several key products including teriparatide injections, cholera vaccines, and human growth hormone preparations. The manufacturing process utilizes both prokaryotic and eukaryotic expression systems.

Strategic location and market access

Located at 1150 Gui Qiao Lu in Shanghai’s Free Trade Zone, the facility benefits from the region’s established biotechnology infrastructure and proximity to major transportation networks. This position supports efficient distribution across Asian markets while maintaining compliance with international standards.

Services provided by Shanghai Yusong Biotechnology

Below you will find the services provided by Belchem. Like each cosmetic lab on the platform, the services are manually registered by the providing company.

  • Shanghai Yusong Biotechnology has no service catalogue on cosmetic-labs.com.
  • Shanghai Yusong Biotechnology has not yet posted any media. There is no gallery yet.

Locate Shanghai Yusong Biotechnology

Contact Shanghai Yusong Biotechnology

  • Shanghai Yusong Biotechnology has not yet been verified. Messaging is disabled.

Shanghai Yusong Biotechnology opening hours

Closed all day

  • Monday

    Closed all day
  • Tuesday

    Closed all day
  • Wednesday

    Closed all day
  • Thursday

    Closed all day
  • Friday

    Closed all day
  • Saturday

    Closed all day
  • Sunday

    Closed all day
  • Local time

    August 3, 2025 8:38 am

Shanghai United Cell Biotechnology manufactures biological products in these categories:

  • Therapeutic Injections
    • Teriparatide injection
    • Human growth hormone injection
    • Freeze-dried powder injections
    • Cartridge vial injections
  • Vaccines
    • Recombinant B subunit cholera vaccine
    • Whole cell cholera vaccine (enteric-coated capsules)
  • Other Formulations
    • Capsule products
    • Granule products

Annual production capacity includes 15 million freeze-dried injections, 13 million cartridge vial injections, 9 million capsules, and 5.6 million bags of granules.

The company maintains these R&D and manufacturing standards:

Category Details
Research Platforms
  • Prokaryotic expression systems
  • Eukaryotic expression systems
  • Gene engineering technology
Therapeutic Areas
  • Endocrinology
  • Orthopedics
  • Ophthalmology
  • Anti-infection
Quality Systems
  • GMP-compliant facilities
  • 10% revenue R&D investment
  • Biological product standards

The company operates from the following facilities:

  • Manufacturing Complex
    • 20,000 square meter facility footprint
    • 24,000 square meter total building area
    • Located in Shanghai Free Trade Zone
  • Production Workshops
    • Genetic engineering bulk production
    • Cholera vibrio bulk production
    • Injection production units
    • Capsule manufacturing area
    • Granule processing section

Primary Location:

Shanghai United Cell Biotechnology
Jinqiao Biotechnology Industrial Park
Shanghai Free Trade Zone
Shanghai, China
Explore

Find a cosmetic lab in China

Click below to see the profile of a cosmetic lab similar to Shanghai Yusong Biotechnology in China.

MCTech’s cosmetic lab in Siheung-si, South Korea specializes in membrane emulsification technology for emulsifier-free cosmetic manufacturing.
No description.
Dow’s cosmetic lab in Bangkok develops sustainable beauty solutions, including award-winning MaizeCareâ„¢ Clarity polymers and eco-conscious formulations for the Thai market.
Centre de Promotion des Exportations in Tunis provides export facilitation services and manages trade development programs across Tunisia and Sub-Saharan Africa.
Hanjoo C&C Co., Ltd. in Gyeonggi-Do serves South Korea’s cosmetics industry through raw material distribution, partnerships and market expertise since 1998.
Industria Quimica Anastacio operates 8 distribution centers in Brazil and serves the Latin American market through facilities in Argentina and Mexico.